Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT06025253 Not yet recruiting - Wound Infection Clinical Trials

PINTA - Prophylactic Incisional Negative Pressure Therapy for Major Amputations

PINTA
Start date: December 1, 2023
Phase: N/A
Study type: Interventional

Post-operative wound issues in abdominal surgery have a significant impact on patient outcomes. This study is taking place to investigate if Negative Pressure Wound Therapy (NPWT) dressings reduces Surgical Site Infections, post surgical complications and improves scar appearance compared to standard dressings.

NCT ID: NCT06024122 Not yet recruiting - Clinical trials for TBI (Traumatic Brain Injury)

Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study

KAOUENN
Start date: September 2, 2023
Phase:
Study type: Observational

Concussions (also known as mild traumatic brain injury) are common in young children. In some children, they can lead to short- and long-term difficulties. However, our knowledge of the exact consequences of injuries on young children's brains and behavior is limited. These consequences may be different in children under 6, as their brains are fragile and undergoing significant developmental changes. The aim of this study is to determine the extent to which a concussion sustained before the age of 6 years is associated with changes in young children's brain structure, function and behaviours, using a brain imaging. In this study, the results of a group of 30 children with a concussion will be compared to those of 30 children of the same age with an orthopaedic injury to the upper or lower limbs.

NCT ID: NCT06017193 Not yet recruiting - Alveolar Bone Loss Clinical Trials

Ultrasound for Socket Healing Evaluation

Start date: June 1, 2024
Phase:
Study type: Observational

The design is a single blinded, dual comparative study of ultrasound versus micro-CT/LASCA in one study group. Up to a total of 140 subjects registered will be recruited. Subjects who are treatment planned for extraction of a hopeless tooth and socket augmentation with bone graft and are planned for a dental implant surgery. The socket will be evaluated before the extraction and multi-time points during healing until an implant is placed with various evaluation tools, including ultrasound.

NCT ID: NCT06016803 Not yet recruiting - Superficial Wound Clinical Trials

Evaluation of the Tolerance of the Medical Device RL3010A - DP0378 in Children and Adults Presenting a Superficial Wound After a Dermatological Procedure

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The CE-marketed medical device class IIa RL3010A - DP0378 developed by Pierre Fabre Laboratories is indicated in the treatment of superficial wounds and abrasions. It forms a protective layer on the surface of wounds maintaining a moist environment improving the healing process thanks to its moisturizing and film-forming effect. Through this study, the overall tolerance of the medical device will be evaluated in subjects presenting a superficial wound after having undergone a dermatological procedure as cryotherapy, laser (laser Nd Yag, fractional laser C02), Intense Pulse Light (IPL) or skin lesion excision for which stitches were removed.

NCT ID: NCT06003712 Not yet recruiting - Quality of Life Clinical Trials

Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI)

Start date: August 31, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if practicing mindfulness breathing exercises has an effect on the overall health of persons with SCI

NCT ID: NCT06003166 Not yet recruiting - Clinical trials for Peripheral Nerve Injury

4-AP Peripheral Nerve Crossover Trial

Start date: April 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the role of single dose 4-aminopyridine (4-AP) on the diagnosis of severing vs non-severing nerve injury after peripheral nerve traction and/or crush injury. The investigational treatment will be used to test the hypothesis that 4-aminopyridine can speed the determination of nerve continuity after peripheral nerve traction and/or crush injuries allowing the identification of incomplete injuries earlier than standard electrodiagnostic (EDX) and clinical assessment. Participants will be randomized to one of two groups to determine the order of treatment they receive (drug and placebo vs placebo and drug). Participants will undergo baseline testing for nerve assessment, receive either drug or placebo based on randomization and undergo hourly sensory and motor evaluation, EDX testing and serum 4AP levels for three hours after dosing. Participants will then repeat this with the crossover arm.

NCT ID: NCT06001216 Not yet recruiting - Injury;Sports Clinical Trials

The Relationship of ACWR and FMS With Injury Risk in Adolescent Players

Start date: August 18, 2023
Phase:
Study type: Observational

In this study, we examine how acute to chronic workload ratio and functional movement screen scores relate to injury risk in teenage athletes who play team sports.

NCT ID: NCT05993364 Not yet recruiting - Clinical trials for Acquired Brain Injury

Efficacy of EFA in Acquired Brain Injury

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

Acquired brain injury (ABI) is one of the biggest cause of death and disability in the world. Patients with ABI often have difficulties with swallow and breath. The study purpose is to evaluate if the Expiratory Flow Accelerator (EFA) technology has positive effects on the respiratory and swallowing function in patients with acquired brain injury (ABI). Researchers recruit patients at Centro Ettore Spalenza-Fondazione Don Carlo Gnocchi in Rovato, Italy. To partecipate, patients should satisfy certain eligibility criteria; they will not be enrolled if they satisfy exclusion criteria. If a patient can be recruited, researchers conduct the baseline assessment lasting 1 one week. After that, the patient will be randomized to the study or control group. If the patient is in the control group, he will receive a traditional rehabilitation treatment. Otherwise, the patient will receive an additional treatment with the EFA device. Researchers will assess again the patient (with the same procedures of baseline assessment) after 8 weeks of treatment. They want to see if the EFA device could help patients with ABI to improve their health conditions.

NCT ID: NCT05989230 Not yet recruiting - Chronic Pain Clinical Trials

Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma

Start date: August 2024
Phase: N/A
Study type: Interventional

The purpose of this single-arm trial is to determine the feasibility of emotional awareness and expression therapy (EAET) for individuals with persistent pain following orthopedic trauma. As part of this study, participants will be asked to attend weekly EAET treatment sessions and complete assessments (including pre-treatment, post-treatment, and follow-up) consisting of questionnaires and sensory testing procedures.

NCT ID: NCT05983549 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial

LIMIT
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Feasibility and safety of targeting neutral vs liberal fluid balance in traumatic brain injured patients: a phase II randomized controlled trial